International Biotechnology (LON:IBT - Get Free Report)'s stock price passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 684.42 ($8.37) and traded as high as GBX 703.25 ($8.60). International Biotechnology shares last traded at GBX 702 ($8.59), with a volume of 145,383 shares traded.
International Biotechnology Stock Performance
The firm has a market capitalization of £258.72 million, a price-to-earnings ratio of 1,458.33 and a beta of 0.21. The firm's 50 day simple moving average is GBX 695.23 and its 200 day simple moving average is GBX 684.54. The company has a debt-to-equity ratio of 9.66, a quick ratio of 0.32 and a current ratio of 0.46.
International Biotechnology Increases Dividend
The firm also recently announced a dividend, which will be paid on Friday, January 24th. Investors of record on Thursday, December 19th will be given a dividend of GBX 15.56 ($0.19) per share. The ex-dividend date is Thursday, December 19th. This is an increase from International Biotechnology's previous dividend of $14.50. This represents a yield of 2.21%. International Biotechnology's payout ratio is currently 6,041.67%.
Insiders Place Their Bets
In related news, insider Katherine Cornish-Bowden purchased 1,500 shares of the firm's stock in a transaction on Tuesday, December 17th. The stock was bought at an average cost of GBX 713 ($8.72) per share, with a total value of £10,695 ($13,085.77). 4.18% of the stock is owned by insiders.
International Biotechnology Company Profile
(
Get Free Report)
The Company's investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies.
The Company will seek to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have good growth prospects, with experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology.
Read More
Before you consider International Biotechnology, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and International Biotechnology wasn't on the list.
While International Biotechnology currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
